Many people are carriers of hepatitis C and do not realize it. These activities include intravenous drug use, body piercing, and tattooing. Blood transfusion prior to 1990 is also a risk factor. Patients who engaged in these activities should undergo liver screening to determine if they are a carrier of hepatitis C. Anti-viral drugs, such as Interferon, for treatment of hepatitis C have b een available for over 10 years. Yet, despite the advances in medical treatment, many patients progress to end-stage liver disease requiring liver transplant.
Studies are currently underway using long-acting medications to further increase the success rate.
Froed tert and the Medical College have performed over 500 successful liver transplants, establishing themselves as a premier center for liver diseases and liver transplantation. Research is ongoing by DDC investigators to study n ew drugs and identify treatment strategies that can improve outcomes for patients with hepatitis C and other liver diseases. To learn more about our ph ysicians as well as upcoming educational events, visit our Division page. For information about our specialty clinics, current research, and ongoing clinical trials, v isit our public information page. That area also includes three health quizzes to help you decide whether or not to seek medical help with a gastroenterological problem.